Positions 76–100 of 130.
Here it is: 4 weeks on 15mg, full numbers, ask me anything boring. One person, one log, no control group, so read it accordingly. 4 weeks and 15mg — those are the…
The title is the argument: the TRIUMPH thing finally clicked for me and I want to write it down. Here is the rest of it. Independent purity testing on this compound is…
what would you tell week-1 you about glucagon, and I want the answer with the reasoning attached rather than just the conclusion. Sent a vial to Medutest out of…
5 months in and dose escalation is still the thing I get wrong. Same spreadsheet I have been keeping since the start, nothing retrofitted. Numbers, in the order they…
Vendor-level purity averages over time, built from independent results rather than vendor claims. Transparent methodology, open dataset.
Browse resultstried triple agonist for 19 weeks. here is what happened, and I am aware this is a minority view on this board. The numbers the title promised, since a headline without…
genuine question about TRIUMPH that I am slightly embarrassed to ask. I am not trying to be the "source?" guy. I would just like a source. Increases in heart rate have…
Filing this under things worth writing down: 9th independent test on QYB — 97.7% on a claimed 97.0%, and the trend is the interesting part. Numbers, in the order they…
split one vial across VendorInvestigate and PeptideMeter — 98.6% and 93.7%. I will put the method line and the batch identifier up front because that is what makes this…
The title is the argument: dose escalation — my 16-week log, condensed into one table. Here is the rest of it. It is a triple agonist at the GLP-1, GIP and glucagon…
stalled for 12 weeks at 10mg and I refuse to panic this time. It is the sort of thing everyone half-believes and nobody writes down. 12 weeks and 10mg — those are the…
triple agonist: the version I wish someone had shown me in week 1. Numbers below. Ask me the boring questions, they are the useful ones. It is a triple agonist at the…
can we stop arguing about dose escalation until somebody posts a number. Searched first, found three threads that contradict each other, hence the post. Went up slowly,…
Short version of the title, which is already short: WXT reta — PeptideMeter came back 97.7% against a claimed 97.0%. Longer version underneath. Pulling the figures out…
stalled for 11 weeks at 12.5mg and I refuse to panic this time, and I am aware this is a minority view on this board. The relevant figures are 11 weeks and 12.5mg, and…
Numbers in the title, numbers in the post. QSC vs Homopeptide on the same compound, same month — both cleared 98.5%. Figures up front so nobody has to dig: 98.5%. Sent…
Reference standards, analytical reagents and system-suitability material. If you are running your own method, start with a known.
Reference standardsPosting this as a discussion rather than a claim: TRIUMPH — 16 things I got wrong before I got it right. What the glucagon arm is doing, as best anyone can say from…
genuine question about phase 2 that I am slightly embarrassed to ask. If this has been answered properly somewhere, link me and I will delete. Read the phase 2 paper…
Slightly embarrassed to be asking this, but: am I the only one who found triple agonist harder than the injections. Stopped at a low step because there was no reason to…
Check-in as promised in the title: is it normal to get early fullness at week 64. Nothing containing this compound is approved anywhere. Research-use-only material is…
small win: dose escalation stopped being a problem at week 19. This is a description of what happened to me and not a plan for anybody else. What the glucagon arm is…
unpopular opinion: most of what gets said here about phase 2 is guesswork. Change my mind, genuinely — I have no stake in being right about this. The standing caveat,…
Slightly embarrassed to be asking this, but: genuine question about dose escalation that I am slightly embarrassed to ask. The early fullness profile felt different…
Check-in as promised in the title: 45 weeks on 0.25mg, full numbers, ask me anything boring. The numbers the title promised, since a headline without them is worthless:…
Trying to get a straight answer on this: triple agonist — what am I missing here. Watched heart rate on a wearable across twelve weeks because the threads said to. It…
Reporting in. 3 months in and triple agonist is still the thing I get wrong. The numbers the title promised, since a headline without them is worthless: 3 months.…
Retatrutide: GIP/GLP-1/glucagon triple agonism, the TRIUMPH programme, and the fact that most people discussing it are handling research-grade material with no human-use approval anywhere. Dose-response, heart-rate signal, and the unusually steep phase-2 weight curves get argued about here weekly.
Certified reference materials for peptide identity and purity work.
sigmaaldrich.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference